Vytrus Biotech, S.A. (BME:VYT)
Spain
· Delayed Price · Currency is EUR 8.50
+0.40 (4.94%)
At close: Dec 5, 2025
Vytrus Biotech Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Cash & Equivalents | 3.29 | 2.53 | 1.1 | 0.72 | 1.28 | 1.09 | Upgrade
|
| Short-Term Investments | 0 | 0 | 0 | - | 0 | 0 | Upgrade
|
| Cash & Short-Term Investments | 3.29 | 2.53 | 1.11 | 0.72 | 1.28 | 1.09 | Upgrade
|
| Cash Growth | 48.08% | 128.81% | 52.54% | -43.56% | 17.37% | 31.98% | Upgrade
|
| Accounts Receivable | 1.32 | 0.62 | 0.55 | 0.44 | 0.21 | 0.17 | Upgrade
|
| Other Receivables | 0.11 | 0.11 | 0.23 | 0.09 | 0.05 | 0.05 | Upgrade
|
| Receivables | 1.43 | 0.73 | 0.78 | 0.53 | 0.27 | 0.21 | Upgrade
|
| Inventory | 0.49 | 0.54 | 0.56 | 0.43 | 0.26 | 0.21 | Upgrade
|
| Other Current Assets | 0.01 | - | - | - | 0.01 | 0.02 | Upgrade
|
| Total Current Assets | 5.22 | 3.79 | 2.45 | 1.68 | 1.82 | 1.54 | Upgrade
|
| Property, Plant & Equipment | 1.07 | 0.86 | 0.93 | 1.03 | 0.68 | 0.57 | Upgrade
|
| Long-Term Investments | 0.1 | 0.09 | 0.09 | 0.07 | 0.04 | 0.01 | Upgrade
|
| Other Intangible Assets | 4.39 | 4.08 | 3.63 | 3.15 | 2.84 | 2.53 | Upgrade
|
| Long-Term Deferred Tax Assets | 2.38 | 2.32 | 2.22 | 2.07 | 1.81 | 1.55 | Upgrade
|
| Total Assets | 13.17 | 11.13 | 9.31 | 8 | 7.18 | 6.21 | Upgrade
|
| Accounts Payable | 0.09 | 0.1 | 0.04 | 0.17 | 0.16 | 0.08 | Upgrade
|
| Accrued Expenses | 0.27 | 0.38 | 0.07 | 0.17 | 0.16 | 0.05 | Upgrade
|
| Current Portion of Long-Term Debt | 0.38 | 0.38 | 0.34 | 0.25 | 0.19 | 0.2 | Upgrade
|
| Other Current Liabilities | 0.95 | 0.4 | 0.54 | 0.68 | 0.29 | 0.32 | Upgrade
|
| Total Current Liabilities | 1.69 | 1.25 | 1 | 1.27 | 0.81 | 0.64 | Upgrade
|
| Long-Term Debt | 1.04 | 1.39 | 1.73 | 0.74 | 0.74 | 0.67 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.83 | 0.59 | 0.66 | 0.69 | 0.59 | 0.47 | Upgrade
|
| Other Long-Term Liabilities | 0.71 | 0.6 | 0.63 | 0.55 | 0.8 | 0.82 | Upgrade
|
| Total Liabilities | 4.27 | 3.84 | 4.02 | 3.25 | 2.93 | 2.6 | Upgrade
|
| Common Stock | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade
|
| Additional Paid-In Capital | 4.63 | 4.63 | 3.4 | 3.4 | 3.4 | 3.15 | Upgrade
|
| Retained Earnings | 4.2 | 1.32 | 1.45 | 1.21 | 0.7 | 0.1 | Upgrade
|
| Treasury Stock | -0.19 | -0.28 | -0.9 | -0.59 | -0.23 | -0.03 | Upgrade
|
| Comprehensive Income & Other | 0.19 | 1.55 | 1.26 | 0.66 | 0.31 | 0.32 | Upgrade
|
| Shareholders' Equity | 8.9 | 7.29 | 5.29 | 4.75 | 4.25 | 3.61 | Upgrade
|
| Total Liabilities & Equity | 13.17 | 11.13 | 9.31 | 8 | 7.18 | 6.21 | Upgrade
|
| Total Debt | 1.42 | 1.77 | 2.08 | 0.98 | 0.93 | 0.87 | Upgrade
|
| Net Cash (Debt) | 1.87 | 0.76 | -0.97 | -0.26 | 0.35 | 0.22 | Upgrade
|
| Net Cash Growth | 865.32% | - | - | - | 57.68% | - | Upgrade
|
| Net Cash Per Share | - | 0.10 | -0.14 | - | 0.05 | 0.03 | Upgrade
|
| Filing Date Shares Outstanding | - | 7.52 | 6.74 | - | 6.93 | 6.9 | Upgrade
|
| Total Common Shares Outstanding | - | 7.52 | 6.74 | - | 6.93 | 6.9 | Upgrade
|
| Working Capital | 3.53 | 2.54 | 1.46 | 0.41 | 1.01 | 0.89 | Upgrade
|
| Book Value Per Share | - | 0.97 | 0.79 | - | 0.61 | 0.52 | Upgrade
|
| Tangible Book Value | 4.51 | 3.22 | 1.66 | 1.6 | 1.42 | 1.08 | Upgrade
|
| Tangible Book Value Per Share | - | 0.43 | 0.25 | - | 0.20 | 0.16 | Upgrade
|
| Buildings | - | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Machinery | - | 1.37 | 1.28 | 1.34 | 0.88 | 0.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.